Fragment Based Drug Discovery: Practical Implementation Based on 19F NMR Spectroscopy

Citations Over TimeTop 11% of 2011 papers

Abstract

Fragment based drug discovery (FBDD) is a widely used tool for discovering novel therapeutics. NMR is a powerful means for implementing FBDD, and several approaches have been proposed utilizing (1)H-(15)N heteronuclear single quantum coherence (HSQC) as well as one-dimensional (1)H and (19)F NMR to screen compound mixtures against a target of interest. While proton-based NMR methods of fragment screening (FBS) have been well documented and are widely used, the use of (19)F detection in FBS has been only recently introduced (Vulpetti et al. J. Am. Chem. Soc.2009, 131 (36), 12949-12959) with the aim of targeting "fluorophilic" sites in proteins. Here, we demonstrate a more general use of (19)F NMR-based fragment screening in several areas: as a key tool for rapid and sensitive detection of fragment hits, as a method for the rapid development of structure-activity relationship (SAR) on the hit-to-lead path using in-house libraries and/or commercially available compounds, and as a quick and efficient means of assessing target druggability.

Related Papers

• → Heteronuclear Correlation Experiments Such as Heteronuclear Single-Quantum Correlation Spectroscopy (HSQC), Heteronuclear Multiple-Quantum Correlation Spectroscopy (HMQC) and Heteronuclear Multiple-Bond Correlation Spectroscopy (HMBC) Comparative Study On Malignant and Benign Human Endocrinology and Thyroid Cancer Cells and Tissues Under Synchrotron Radiation(2018)90 cited
• → Time-saving methods for heteronuclear multidimensional NMR of (13C, 15N) doubly labeled proteins(1994)55 cited
• → HSQC pulse sequences for 19F(2008)18 cited
• → A novel 15N‐labeling method to selectively observe 15NH₂ resonances of proteins in 1H‐detected heteronuclear correlation spectroscopy(1992)10 cited
• → NMR study on 9‐S and 9‐R oxirane derivatives of ascomycin(2002)5 cited